首页> 外文期刊>International ophthalmology >Acute stroke after intravitreal bevacizumab to treat choroidal neovascularization due to angioid streaks in pseudoxanthoma elasticum : A severe systemic adverse event after an off-label procedure.
【24h】

Acute stroke after intravitreal bevacizumab to treat choroidal neovascularization due to angioid streaks in pseudoxanthoma elasticum : A severe systemic adverse event after an off-label procedure.

机译:玻璃体腔注射贝伐单抗后的急性中风可治疗弹性假性黄瘤中由于血管样条纹而引起的脉络膜新生血管形成:不合规程后发生的严重全身性不良事件。

获取原文
获取原文并翻译 | 示例
       

摘要

To report the occurrence of acute stroke after intravitreal bevacizumab administration to treat choroidal neovascularization due to angioid streaks in a patient affected by pseudoxanthoma elasticum. A 54-year-old man with pseudoxanthoma elasticum had vision loss because of choroidal neovascularization due to angioid streaks. He underwent two intravitreal bevacizumab injections. Three days after the second procedure the patient was afflicted by acute stroke. Intravitreal injection of bevacizumab to treat choroidal neovascularization due to angioid streaks in pseudoxanthoma elasticum could lead to severe systemic adverse events.
机译:报告玻璃体腔注射贝伐珠单抗治疗因弹性假性黄瘤患者而产生的脉络膜新生血管引起的脉络膜新生血管形成后发生急性中风的情况。一名患有弹性假性黄瘤的54岁男子因血管纹状脉络膜新血管形成而导致视力下降。他接受了两次玻璃体内贝伐单抗注射。第二次手术后三天,患者患有急性中风。玻璃体腔注射贝伐单抗治疗由于弹性假黄瘤中血管样条纹而引起的脉络膜新血管形成可能会导致严重的全身不良事件。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号